A detailed history of Kestra Advisory Services, LLC transactions in Annexon, Inc. stock. As of the latest transaction made, Kestra Advisory Services, LLC holds 10,000 shares of ANNX stock, worth $49,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,000
Previous 10,000 -0.0%
Holding current value
$49,000
Previous $45,000 57.78%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$1.63 - $4.63 $17,930 - $50,930
-11,000 Reduced 52.38%
10,000 $45,000
Q3 2023

Nov 09, 2023

SELL
$2.13 - $3.84 $8,520 - $15,360
-4,000 Reduced 16.0%
21,000 $49,000
Q2 2023

Aug 11, 2023

BUY
$2.1 - $6.37 $21,000 - $63,700
10,000 Added 66.67%
25,000 $88,000
Q1 2022

Apr 26, 2022

BUY
$2.73 - $11.94 $40,950 - $179,100
15,000 New
15,000 $40,000

Others Institutions Holding ANNX

About Annexon, Inc.


  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $233M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track Kestra Advisory Services, LLC Portfolio

Follow Kestra Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Advisory Services, LLC with notifications on news.